van Roon JAG - Search Results

1

Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.

van der Kroef M, van den Hoogen LL, Mertens JS, Blokland SLM, Haskett S, Devaprasad A, Carvalheiro T, Chouri E, Vazirpanah N, Cossu M, Wichers CGK, Silva-Cardoso SC, Affandi AJ, Bekker CPJ, Lopes AP, Hillen MR, Bonte-Mineur F, Kok MR, Beretta L, Rossato M, Mingueneau M, van Roon JAG, Radstake TRDJ. van der Kroef M, et al. Among authors: van roon jag, van den hoogen ll. Eur J Immunol. 2020 Jan;50(1):119-129. doi: 10.1002/eji.201948129. Epub 2019 Sep 11. Eur J Immunol. 2020. PMID: 31424086 Free article.

2

Editorial: interleukin-7 and its receptor: the axis of evil to target in Sjögren's syndrome?

van Roon JA, Kruize AA, Radstake TR. van Roon JA, et al. Arthritis Rheum. 2013 Aug;65(8):1980-4. doi: 10.1002/art.38002. Arthritis Rheum. 2013. PMID: 23666552 Free article. No abstract available.

3

Targeting Th2-typified immune responses to prevent immunopathology in rheumatic diseases: belittled therapeutic strategies?

Moret FM, Radstake TR, van Roon JA. Moret FM, et al. Ann Rheum Dis. 2014 Mar;73(3):477-9. doi: 10.1136/annrheumdis-2013-204285. Epub 2013 Dec 9. Ann Rheum Dis. 2014. PMID: 24323396 No abstract available.

4

Overlapping gene expression profiles indicative of antigen processing and the interferon pathway characterize inflammatory fibrotic skin diseases.

Limpers A, van Royen-Kerkhof A, van Roon JA, Radstake TR, Broen JC. Limpers A, et al. Expert Rev Clin Immunol. 2014 Feb;10(2):231-41. doi: 10.1586/1744666X.2014.872561. Epub 2014 Jan 2. Expert Rev Clin Immunol. 2014. PMID: 24382112 Review.

5

Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjögren's syndrome.

Hillen MR, Ververs FA, Kruize AA, Van Roon JA. Hillen MR, et al. Expert Rev Clin Immunol. 2014 Apr;10(4):521-31. doi: 10.1586/1744666X.2014.878650. Epub 2014 Jan 22. Expert Rev Clin Immunol. 2014. PMID: 24450381 Review.

6

Towards inhibition of morbidity and mortality in Sjögren's syndrome: opportunities and challenges.

van Roon JA, Radstake TR. van Roon JA, et al. Expert Rev Clin Immunol. 2014 Apr;10(4):421-3. doi: 10.1586/1744666X.2014.902575. Expert Rev Clin Immunol. 2014. PMID: 24646083

7

Proteome-wide analysis and CXCL4 in systemic sclerosis.

van Roon JA, Tesselaar K, Radstake TR. van Roon JA, et al. N Engl J Med. 2014 Apr 17;370(16):1563-4. doi: 10.1056/NEJMc1402401. N Engl J Med. 2014. PMID: 24738676 No abstract available.

8

Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells.

Moret FM, Hack CE, van der Wurff-Jacobs KM, Radstake TR, Lafeber FP, van Roon JA. Moret FM, et al. Arthritis Rheumatol. 2014 May;66(5):1176-84. doi: 10.1002/art.38338. Arthritis Rheumatol. 2014. PMID: 24782181

9

Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren's syndrome is associated with increased disease activity.

Hillen MR, Kruize AA, Bikker A, Wenting-van Wijk M, Radstake TR, Hack CE, Lafeber FP, van Roon JA. Hillen MR, et al. Mod Rheumatol. 2016;26(1):105-9. doi: 10.3109/14397595.2015.1054089. Epub 2015 Sep 23. Mod Rheumatol. 2016. PMID: 25995032

10

The Additive Inflammatory In Vivo and In Vitro Effects of IL-7 and TSLP in Arthritis Underscore the Therapeutic Rationale for Dual Blockade.

Hillen MR, Hartgring SA, Willis CR, Radstake TR, Hack CE, Lafeber FP, van Roon JA. Hillen MR, et al. PLoS One. 2015 Jun 25;10(6):e0130830. doi: 10.1371/journal.pone.0130830. eCollection 2015. PLoS One. 2015. PMID: 26110994 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page